LBS

Data Insights

Q2 2024 update: M&A activity in pharmaceutical in Europe

Analyst Comment

Novo Nordisk blockbuster Ozempic boasts 23% sales surge in 2023

Features

BYJU’s, India’s most valuable unicorn, is giving the UK an education in AI technology

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Q2 2024 update: M&A activity in pharmaceutical in Europe

Novo Nordisk blockbuster Ozempic boasts 23% sales surge in 2023

BYJU’s, India’s most valuable unicorn, is giving the UK an education in AI technology

Parenteral Solutions in Contract Manufacturing for the Pharmaceutical Industry

Oral Solid Dosage Manufacturing Companies, Equipment and Market

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief